Acebrophylline - Polichem/Hyundai PharmaceuticalAlternative Names: HOB-051
Latest Information Update: 14 Jun 2016
At a glance
- Originator Polichem
- Developer Hyundai Pharmaceutical; NovoTek; Polichem
- Class Antiasthmatics; Bronchodilators; Xanthines
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Bronchitis
Most Recent Events
- 01 Nov 2015 Phase-III clinical trials in Bronchitis in South Korea (PO, controlled release) (NCT02792946)